The US Food and Drug Administration announced Monday that it has expanded approval of the Covid-19 drug remdesivir to treat patients as young as 28 days and weighing about 7 pounds.
(SOURCE) https://www.cnn.com/2022/04/25/health/fda-remdesivir-covid-treatment-young-children/index.html